Centre Guillaume le Conquérant

The trials here

What the 9 trials at this site are about, from their registry records.

Conditions

• Head and neck cancer7 trials
• Meningioma2 trials

Phase

• Phase 34 trials
• Phase 22 trials

Status

• Recruiting3 trials
• Active, not recruiting2 trials
• Not yet recruiting2 trials
• Suspended1 trial
• Terminated1 trial

Lead sponsor

• Groupe Oncologie Radiotherapie Tete et Cou3 trials
• Centre Francois Baclesse2 trials
• Centre Henri Becquerel1 trial
• EMD Serono Research & Development Institute, Inc.1 trial
• Groupe Oncologie Radiotherapie Tete Cou1 trial
• and 1 more

Running trials

• Recruiting

  Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN

  NCT07264075· Phase 3· Groupe Oncologie Radiotherapie Tete et Cou· Source

• Recruiting

  Clinical Trial Comparing Induction Treatment With EGFR-ADC MRG003 Alone or in Combination With the Anti PD1 Pucotenlimab, Followed by Radiochemotherapy in Locally Advanced Squamous Cell Cancers of the Head and Neck

  NCT06959108· Phase 2· Groupe Oncologie Radiotherapie Tete et Cou· Source

• Recruiting

  Study of TPEx Followed by a Maintenance With Avelumab and Cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma of the H&N

  NCT06640725· Phase 2· Groupe Oncologie Radiotherapie Tete et Cou· Source

• Recruiting

  Long-term Cognitive and Functional Impact of Proton-therapy or Modern Fractionated Radiotherapy in Cavernous Sinus Meningioma: An Open-label Randomized 1:1 Phase III Study

  NCT05895344· Centre Francois Baclesse· Source

  Contact: Paul LESUEUR, MD

• Recruiting

  Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma:

  NCT06036706· Centre Francois Baclesse· Source

  Contact: Paul LESUEUR, MD

• Recruiting

  Optimised Early Management of Squamous Cell Carcinoma of the Head and Neck Cancer

  NCT04528420· Centre Henri Becquerel· Source

  Contact: Laurent Martin, MD

• Active, not recruiting

  Randomized trial evaluating the addition of nivolumab to cisplatin-radiotherapy combination for treatment of cancers of the head and neck

  2024-513206-65-00· Phase 3· Groupe Oncologie Radiotherapie Tete Cou· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Head and neck cancer3 recruiting
• Meningioma2 recruiting

Closed trials

• Terminated

  A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)

  NCT04459715· Phase 3· EMD Serono Research & Development Institute, Inc.· Source